Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply

Bastian Neesgaard¹, Lauren Greenberg², Lars Peters², Amanda Mocroft³, Lene Ryom⁴; writing group and the RESPOND study group

Affiliations

¹ Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark. Electronic address: Bastian.neesgaard@regionh.dk.
² Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark.
³ Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK.
⁴ Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark; Department of Infectious disease, Hvidovre University Hospital, Copenhagen, Denmark.

PMID: 36566083
DOI: 10.1016/S2352-3018(22)00367-8

Comment

Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply

Bastian Neesgaard et al. Lancet HIV. 2023 Jan.

. 2023 Jan;10(1):e9-e10.

doi: 10.1016/S2352-3018(22)00367-8.

Authors

Bastian Neesgaard¹, Lauren Greenberg², Lars Peters², Amanda Mocroft³, Lene Ryom⁴; writing group and the RESPOND study group

Affiliations

¹ Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark. Electronic address: Bastian.neesgaard@regionh.dk.
² Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark.
³ Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK.
⁴ Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Disease Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark; Department of Infectious disease, Hvidovre University Hospital, Copenhagen, Denmark.

PMID: 36566083
DOI: 10.1016/S2352-3018(22)00367-8

No abstract available

PubMed Disclaimer

Conflict of interest statement

AM reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or education events from ViiV Healthcare and Gilead Sciences; payment for expert testimonial from Eiland and Bonnin; and support for attending meetings and travel from ViiV Healthcare. LP reports support for attending meetings and travel from Gilead Sciences. All other authors declare no competing interests.

Comment on

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
Neesgaard B, Greenberg L, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, d'Arminio Monforte A, Vehreschild JJ, Sönnerborg A, Anne AV, Carr A, Bansi-Matharu L, Lundgren JD, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Necsoi C, van der Valk M, Menozzi M, Muccini C, Peters L, Mocroft A, Ryom L. Neesgaard B, et al. Lancet HIV. 2022 Jul;9(7):e474-e485. doi: 10.1016/S2352-3018(22)00094-7. Epub 2022 Jun 7. Lancet HIV. 2022. PMID: 35688166
Tenofovir disoproxil fumarate withdrawal and cardiovascular risk.
Drechsler H, Ayers C, Bedimo R. Drechsler H, et al. Lancet HIV. 2023 Jan;10(1):e8-e9. doi: 10.1016/S2352-3018(22)00362-9. Lancet HIV. 2023. PMID: 36566082 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply

Affiliations

Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical